Dysglycemia in ICU Patients
Dysglycemia has emerged as a very common challenge in critically ill patients, especially with regard to current coronavirus disease 2019 pandemic. Prediabetes, poorly controlled diabetes, pharmaceutical intervention in intensive care unit (ICU) with glucocorticoids, catecholamines and other medicines, and stress response all contribute to dysglycemia in critically ill patients. Early identification and management are the key to prevent further complications. Patient prognosis in terms of clinical outcome, length of ICU stay, and in-hospital morbidity/mortality are adversely affected by patient's dysglycemic status. Apart from hyperglycemia, the other three important pillars of dysglycemia are discussed in this article. Synopsis of early intervention have been captured from India-specific practice guidelines. Important landmark trials have also been captured in this article to provide a clarity on certain aspects of managing dysglycemia in ICUs. Hence, this review article is an attempt to bring forth the salient aspects in diagnosing and managing dysglycemia in critical care settings.
Artikel online veröffentlicht:
01. Juni 2022
© 2022. Official Publication of The Simulation Society (TSS), accredited by International Society of Cardiovascular Ultrasound (ISCU). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 van den Berghe G, Wouters P, Weekers F. et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345 (19) 1359-1367
- 2 Finfer S, Chittock DR, Su SY. et al; NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360 (13) 1283-1297
- 3 Manzanares W, Aramendi I. Stress hyperglycemia and its control with insulin in critically ill patients: current evidence. Med Intensiva 2010; 34 (04) 273-281
- 4 Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive Care Med 2017; 43 (01) 1-15
- 5 Finfer S, Liu B, Chittock DR. et al; NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367 (12) 1108-1118
- 6 Krinsley J, Schultz MJ, Spronk PE. et al. Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Ann Intensive Care 2011; 1: 49
- 7 Braithwaite SS. Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence. Curr Diab Rep 2013; 13 (01) 138-154
- 8 Krinsley JS. Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36 (11) 3008-3013
- 9 Signal M, Le Compte A, Shaw GM, Chase JG. Glycemic levels in critically ill patients: are normoglycemia and low variability associated with improved outcomes?. J Diabetes Sci Technol 2012; 6 (05) 1030-1037
- 10 Omar AS, Salama A, Allam M. et al. Association of time in blood glucose range with outcomes following cardiac surgery. BMC Anesthesiol 2015; 15: 14
- 11 Mehta Y, Mithal A, Kulkarni A. et al. Practice guidelines for enteral nutrition management in dysglycemic critically ill patients: a relook for Indian scenario. Indian J Crit Care Med 2019; 23 (12) 594-603
- 12 Chao WC, Tseng CH, Wu CL, Shih SJ, Yi CY, Chan MC. Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis. Ann Intensive Care 2020; 10 (01) 17
- 13 Olariu E, Pooley N, Danel A, Miret M, Preiser J-C. A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS One 2018; 13 (04) e0194952 DOI: 10.1371/journal.pone.0194952.